A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)
NCT ID: NCT01379963
Last Updated: 2017-07-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
780 participants
OBSERVATIONAL
2009-04-30
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia
NCT01051323
Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine
NCT01309269
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Chronic Kidney Disease Not On Dialysis
NCT01318512
A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
NCT00550680
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
NCT00081471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Renal anemia treated with Mircera for at least 6 months before entering study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Timios Stavros Clinic; Nephrology Department
Aigáleo, , Greece
General Hospital of Artas; Nephrology
Arta, , Greece
Pantokrator Private Clinic; Nephrology
Athens, , Greece
Attikon Center; Nephrology
Athens, , Greece
Athinaiki Private Clinic
Athens, , Greece
Kyanos Stavros Private Hospital; Nephrologic Clinic
Athens, , Greece
Iaso General Private Clinic; Nephrology
Athens, , Greece
Iatriko Athinon Clinic Dafnis; Nephrology Department
Daphni-athens, , Greece
Kyanous Stavros of Patras, Renal Disease Therapy Unit
Pátrai, , Greece
Olympion Therapeytirion; Nefrology
Pátrai, , Greece
Iasis Private Clinic
Piraeus, , Greece
General Hospital Of Chalkidikis; Dialysis Center Unit
Polygyros, , Greece
Diavalkaniko Kentro; Nephrology
Thessaloniki, , Greece
General Hospital of Thessalonikis G.Papanikolaou; Nephrology
Thessaloniki, , Greece
Alfa Nefrodynamiki; Nefrology
Thessaloniki, , Greece
Thessaliki Nossileytiki; Nephrology
Volos, , Greece
General Hospital of Volos; Nephrology
Volos, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML22014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.